Contact
Please use this form to send email to PR contact of this press release:
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Obalon Therapeutics, Inc. (Nasdaq: OBLN) To Contact Brower Piven Before The Lead Plaintiff Deadline
TO: